Related Experiment Video
Updated: Aug 22, 2025
08:15
Gastrointestinal Motility Monitor GIMM
Published on: December 1, 2010
31.0K
Diagnostics of Gastrointestinal Motility and Function: Update for Clinicians
1Gastroenterology Department, Nazareth Hospital, Azrieli Faculty of Medicine, Bar Ilan University, Safed 16100N, Israel.
Diagnostics (Basel, Switzerland)
|November 11, 2022
Summary
Gastrointestinal (GI) motility disorders are common and impact life quality. Understanding these conditions is key to improving patient outcomes and developing new treatments.
Area of Science:
- Gastroenterology
- Physiology
Background:
- Gastrointestinal (GI) motility and function disorders are widespread health issues.
- These conditions significantly impair patients' quality of life.
Discussion:
- The abstract highlights the prevalence and negative impact of GI motility disorders.
- Further research is needed to understand the underlying mechanisms and develop effective therapies.
Key Insights:
- GI motility disorders affect a large portion of the population.
- Impaired GI function leads to a reduced quality of life for affected individuals.
Outlook:
- Future research should focus on novel therapeutic strategies for GI motility dysfunction.
- Advancements in understanding GI physiology could lead to improved patient care.
Related Concept Videos
01:26Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
132
This lesson explores three gastrointestinal imaging techniques: radionuclide testing, colonic transit studies, and virtual colonoscopy.
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
132
01:20Gastrointestinal Motility Disorders
553
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
553
01:16Gastric Motility
990
Gastric motility is the coordinated contraction and relaxation of stomach muscles that convert ingested food into chyme, a semi-liquid substance ready for further digestion in the intestines. The process begins with the vagus nerve inducing the relaxation of the smooth muscles in the fundus and body of the stomach, allowing these regions to expand and accommodate up to approximately 1.5 liters of food and liquid.
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
990
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
372
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
372
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
522
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
522
01:17Assessment of the Gastrointestinal System I: Subjective Data
255
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
255